Intracranial germ cell tumours : I. Experience with platinum based chemotherapy and implications for curative chemoradiotherapy
The results of treatment with platinum based combination chemotherapy in ten patients with intracranial germ cell tumours (GCT) are presented. Two patients, treated for relapse within the central nervous system (CNS), attained partial responses of short duration. One patient with systemic relapse was successfully salvaged with chemotherapy. Seven patients received primary chemotherapy, six of whom received a 'CNS friendly' regimen consisting of vincristine, etoposide, carboplatin (VEJ) prior to craniospinal axis (CSA) irradiation. Three complete and three partial responses, and one patient with stable disease, were seen prior to irradiation. All seven patients are alive and remain disease-free at a median time of 12 months after treatment. Current treatment policy for germinomas attaining complete response to two courses of VEJ is a lowered CSA dose prescription, while non-germinomatous germ cell tumours (NGGCT) receive standard total dose CSA irradiation.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
1992 |
---|---|
Erschienen: |
1992 |
Enthalten in: |
Zur Gesamtaufnahme - volume:4 |
---|---|
Enthalten in: |
Clinical oncology (Royal College of Radiologists (Great Britain)) - 4(1992), 6 vom: 01. Nov., Seite 345-50 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sebag-Montefiore, D J [VerfasserIn] |
---|
Themen: |
11056-06-7 |
---|
Anmerkungen: |
Date Completed 21.01.1993 Date Revised 11.09.2019 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM012616893 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM012616893 | ||
003 | DE-627 | ||
005 | 20231221053105.0 | ||
007 | tu | ||
008 | 231221s1992 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0042.xml |
035 | |a (DE-627)NLM012616893 | ||
035 | |a (NLM)1281421 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sebag-Montefiore, D J |e verfasserin |4 aut | |
245 | 1 | 0 | |a Intracranial germ cell tumours |b I. Experience with platinum based chemotherapy and implications for curative chemoradiotherapy |
264 | 1 | |c 1992 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 21.01.1993 | ||
500 | |a Date Revised 11.09.2019 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a The results of treatment with platinum based combination chemotherapy in ten patients with intracranial germ cell tumours (GCT) are presented. Two patients, treated for relapse within the central nervous system (CNS), attained partial responses of short duration. One patient with systemic relapse was successfully salvaged with chemotherapy. Seven patients received primary chemotherapy, six of whom received a 'CNS friendly' regimen consisting of vincristine, etoposide, carboplatin (VEJ) prior to craniospinal axis (CSA) irradiation. Three complete and three partial responses, and one patient with stable disease, were seen prior to irradiation. All seven patients are alive and remain disease-free at a median time of 12 months after treatment. Current treatment policy for germinomas attaining complete response to two courses of VEJ is a lowered CSA dose prescription, while non-germinomatous germ cell tumours (NGGCT) receive standard total dose CSA irradiation | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 7 | |a Bleomycin |2 NLM | |
650 | 7 | |a 11056-06-7 |2 NLM | |
650 | 7 | |a Vincristine |2 NLM | |
650 | 7 | |a 5J49Q6B70F |2 NLM | |
650 | 7 | |a Etoposide |2 NLM | |
650 | 7 | |a 6PLQ3CP4P3 |2 NLM | |
650 | 7 | |a Carboplatin |2 NLM | |
650 | 7 | |a BG3F62OND5 |2 NLM | |
650 | 7 | |a Cisplatin |2 NLM | |
650 | 7 | |a Q20Q21Q62J |2 NLM | |
700 | 1 | |a Douek, E |e verfasserin |4 aut | |
700 | 1 | |a Kingston, J E |e verfasserin |4 aut | |
700 | 1 | |a Plowman, P N |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical oncology (Royal College of Radiologists (Great Britain)) |d 1995 |g 4(1992), 6 vom: 01. Nov., Seite 345-50 |w (DE-627)NLM012616885 |x 1433-2981 |7 nnns |
773 | 1 | 8 | |g volume:4 |g year:1992 |g number:6 |g day:01 |g month:11 |g pages:345-50 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 4 |j 1992 |e 6 |b 01 |c 11 |h 345-50 |